# Beneficient: financial statements, quarterly

BENF · Nasdaq · CIK 1775734 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/benf.md) · [Financials](/companies/benf/financials.md) · [Filings](/companies/benf/filings.md) · [Insiders](/companies/benf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/benf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(42.8)](/filings/0001775734-24-000074.md) | [(10.2)](/filings/0001775734-25-000010.md) | [(43.0) d](/filings/0001775734-25-000022.md) | [10.0](/filings/0001775734-25-000038.md) | [8.6](/filings/0001775734-25-000049.md) | [4.4](/filings/0001775734-26-000012.md) | [(31.0) d](/filings/0001775734-26-000018.md) | [(12.6)](/filings/0001775734-26-000030.md) | [(2.8)](/filings/0001775734-25-000049.md) | [18.7](/filings/0001775734-26-000012.md) | [(42.4) d](/filings/0001775734-26-000018.md) | [12.2](/filings/0001775734-26-000030.md) |
| Operating income | $m | [(382)](/filings/0001775734-24-000074.md) | [(916)](/filings/0001775734-25-000010.md) | [(195) d](/filings/0001775734-25-000022.md) | [44.3](/filings/0001775734-25-000038.md) | [(13.7)](/filings/0001775734-25-000049.md) | [(9.5)](/filings/0001775734-26-000012.md) | [(45.3) d](/filings/0001775734-26-000018.md) | [(92.6)](/filings/0001775734-26-000030.md) | [(17.9)](/filings/0001775734-25-000049.md) | [3.9](/filings/0001775734-26-000012.md) | [(59.9) d](/filings/0001775734-26-000018.md) | [(0.4)](/filings/0001775734-26-000030.md) |
| Interest expense | $m | [5.1](/filings/0001775734-23-000015.md) | [4.7](/filings/0001775734-24-000002.md) | [4.0 d](/filings/0001775734-24-000029.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001775734-24-000074.md) | [0.1](/filings/0001775734-25-000010.md) | [0.7 d](/filings/0001775734-25-000022.md) | [0.0](/filings/0001775734-25-000038.md) | [0.0](/filings/0001775734-25-000049.md) | [0.7](/filings/0001775734-26-000012.md) | [(0.7) d](/filings/0001775734-26-000018.md) | [0.0](/filings/0001775734-26-000030.md) | [0.0](/filings/0001775734-25-000049.md) | [0.0](/filings/0001775734-26-000012.md) | [0.2 d](/filings/0001775734-26-000018.md) | [0.0](/filings/0001775734-26-000030.md) |
| Net income | $m | [(382)](/filings/0001775734-24-000074.md) | [(925)](/filings/0001775734-25-000010.md) | [367 d](/filings/0001775734-24-000029.md) | [44.3](/filings/0001775734-25-000038.md) | [9.7](/filings/0001775734-25-000049.md) | [(8.6)](/filings/0001775734-26-000012.md) | [(0.8) d](/filings/0001775734-26-000018.md) | [(65.1)](/filings/0001775734-26-000030.md) | [(17.9)](/filings/0001775734-25-000049.md) | [19.9](/filings/0001775734-26-000012.md) | [(38.6) d](/filings/0001775734-26-000018.md) | [(6.8)](/filings/0001775734-26-000030.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.4](/filings/0001775734-23-000015.md) | [11.2](/filings/0001775734-24-000002.md) | [7.9](/filings/0001775734-25-000022.md) | [4.4](/filings/0001775734-24-000058.md) | [4.5](/filings/0001775734-24-000074.md) | [4.1](/filings/0001775734-25-000010.md) | [1.3](/filings/0001775734-26-000018.md) | [7.6](/filings/0001775734-25-000038.md) | [4.9](/filings/0001775734-25-000049.md) | [7.9](/filings/0001775734-26-000012.md) | [2.5](/filings/0001775734-26-000030.md) | [5.6](/filings/0001775734-26-000030.md) |
| Total assets | $m | [1,457](/filings/0001775734-23-000015.md) | [501](/filings/0001775734-24-000002.md) | [369](/filings/0001775734-25-000022.md) | [361](/filings/0001775734-24-000058.md) | [369](/filings/0001775734-24-000074.md) | [400](/filings/0001775734-25-000010.md) | [355](/filings/0001775734-26-000018.md) | [335](/filings/0001775734-25-000038.md) | [316](/filings/0001775734-25-000049.md) | [338](/filings/0001775734-26-000012.md) | [239](/filings/0001775734-26-000030.md) | [251](/filings/0001775734-26-000030.md) |
| Total liabilities | $m | [274](/filings/0001775734-23-000015.md) | [246](/filings/0001775734-24-000002.md) | [310](/filings/0001775734-25-000022.md) | [259](/filings/0001775734-24-000058.md) | [256](/filings/0001775734-24-000074.md) | [295](/filings/0001775734-25-000010.md) | [299](/filings/0001775734-26-000018.md) | [364](/filings/0001775734-25-000038.md) | [369](/filings/0001775734-25-000049.md) | [376](/filings/0001775734-26-000012.md) | [338](/filings/0001775734-26-000030.md) | [345](/filings/0001775734-26-000030.md) |
| Shareholders' equity | $m | [932](/filings/0001775734-25-000010.md) | [4.0](/filings/0001775734-25-000010.md) | [(192)](/filings/0001775734-26-000018.md) | [(148)](/filings/0001775734-25-000049.md) | [(13.2)](/filings/0001775734-26-000012.md) | [14.3](/filings/0001775734-26-000012.md) | [(34.9)](/filings/0001775734-26-000030.md) | [(120)](/filings/0001775734-26-000030.md) | [(143)](/filings/0001775734-26-000012.md) | [(129)](/filings/0001775734-26-000012.md) | [(189)](/filings/0001775734-26-000030.md) | [(184)](/filings/0001775734-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(13.4) d](/filings/0001775734-24-000074.md) | [(22.2) d](/filings/0001775734-25-000010.md) | [(8.6) d](/filings/0001775734-25-000022.md) | [(10.6)](/filings/0001775734-25-000038.md) | [(8.6) d](/filings/0001775734-25-000049.md) | [(10.0) d](/filings/0001775734-26-000012.md) | [(8.4) d](/filings/0001775734-26-000018.md) | [(10.8)](/filings/0001775734-26-000030.md) | [(14.5) d](/filings/0001775734-25-000049.md) | [(9.4) d](/filings/0001775734-26-000012.md) | [(4.0) d](/filings/0001775734-26-000018.md) | [(4.1)](/filings/0001775734-26-000030.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001775734-24-000074.md) | [0.4 d](/filings/0001775734-25-000010.md) | [0.4 d](/filings/0001775734-25-000022.md) | [0.7](/filings/0001775734-25-000038.md) | [0.3 d](/filings/0001775734-25-000049.md) | [0.0 d](/filings/0001775734-26-000012.md) | [0.1 d](/filings/0001775734-26-000018.md) | [0.1](/filings/0001775734-26-000030.md) | [0.0 d](/filings/0001775734-25-000049.md) | [0.0 d](/filings/0001775734-26-000012.md) | [0.0 d](/filings/0001775734-26-000018.md) | [0.0](/filings/0001775734-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2021-03-31) | period not labelled (2022-03-31) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.2](/filings/0001775734-23-000008.md) | [67.5](/filings/0001775734-23-000008.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.